Logo image of OBE.CA

OBSIDIAN ENERGY LTD (OBE.CA) Stock Fundamental Analysis

TSX:OBE - Toronto Stock Exchange - CA6744822033 - Common Stock - Currency: CAD

7.66  +0.13 (+1.73%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OBE. OBE was compared to 207 industry peers in the Oil, Gas & Consumable Fuels industry. OBE has a medium profitability rating, but doesn't score so well on its financial health evaluation. OBE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

OBE had negative earnings in the past year.
OBE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OBE reported negative net income in multiple years.
OBE had a positive operating cash flow in each of the past 5 years.
OBE.CA Yearly Net Income VS EBIT VS OCF VS FCFOBE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

With a Return On Assets value of -9.16%, OBE is not doing good in the industry: 62.32% of the companies in the same industry are doing better.
OBE has a Return On Equity (-14.10%) which is in line with its industry peers.
With an excellent Return On Invested Capital value of 8.14%, OBE belongs to the best of the industry, outperforming 85.99% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for OBE is in line with the industry average of 7.39%.
Industry RankSector Rank
ROA -9.16%
ROE -14.1%
ROIC 8.14%
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
OBE.CA Yearly ROA, ROE, ROICOBE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

The Operating Margin of OBE (26.36%) is better than 77.29% of its industry peers.
In the last couple of years the Operating Margin of OBE has declined.
With an excellent Gross Margin value of 70.77%, OBE belongs to the best of the industry, outperforming 89.37% of the companies in the same industry.
OBE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.36%
PM (TTM) N/A
GM 70.77%
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
OBE.CA Yearly Profit, Operating, Gross MarginsOBE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OBE is destroying value.
OBE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for OBE has been increased compared to 5 years ago.
OBE has a worse debt/assets ratio than last year.
OBE.CA Yearly Shares OutstandingOBE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
OBE.CA Yearly Total Debt VS Total AssetsOBE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

OBE has an Altman-Z score of 0.71. This is a bad value and indicates that OBE is not financially healthy and even has some risk of bankruptcy.
OBE has a Altman-Z score (0.71) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.25 indicates that OBE is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.25, OBE is doing good in the industry, outperforming 61.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACC0.86
WACC9.51%
OBE.CA Yearly LT Debt VS Equity VS FCFOBE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

OBE has a Current Ratio of 1.56. This is a normal value and indicates that OBE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.56, OBE is in the better half of the industry, outperforming 74.88% of the companies in the same industry.
OBE has a Quick Ratio of 1.56. This is a normal value and indicates that OBE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OBE (1.56) is better than 76.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
OBE.CA Yearly Current Assets VS Current LiabilitesOBE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OBE have decreased strongly by -347.08% in the last year.
Looking at the last year, OBE shows a quite strong growth in Revenue. The Revenue has grown by 15.94% in the last year.
Measured over the past years, OBE shows a quite strong growth in Revenue. The Revenue has been growing by 13.38% on average per year.
EPS 1Y (TTM)-347.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)15.94%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%12.33%

3.2 Future

Based on estimates for the next years, OBE will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
OBE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.29% yearly.
EPS Next Y120.67%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.95%
Revenue Next 2Y-3.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBE.CA Yearly Revenue VS EstimatesOBE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
OBE.CA Yearly EPS VS EstimatesOBE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBE.CA Price Earnings VS Forward Price EarningsOBE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OBE is valued cheaper than 95.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.03
OBE.CA Per share dataOBE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

OBE's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBSIDIAN ENERGY LTD

TSX:OBE (7/11/2025, 7:00:00 PM)

7.66

+0.13 (+1.73%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners27.43%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap530.15M
Analysts72.5
Price Target9.69 (26.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-84.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF N/A
P/OCF 1.33
P/B 0.38
P/tB 0.38
EV/EBITDA 2.03
EPS(TTM)-2.69
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)5.78
OCFY75.43%
SpS11.04
BVpS20.4
TBVpS20.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.16%
ROE -14.1%
ROCE 10.83%
ROIC 8.14%
ROICexc 8.15%
ROICexgc 8.15%
OM 26.36%
PM (TTM) N/A
GM 70.77%
FCFM N/A
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
ROICexc(3y)8.83%
ROICexc(5y)8.4%
ROICexgc(3y)8.83%
ROICexgc(5y)8.4%
ROCE(3y)11.73%
ROCE(5y)11.13%
ROICexcg growth 3Y-18.98%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.98%
ROICexc growth 5YN/A
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 0.81
Cap/Depr 187.25%
Cap/Sales 57.68%
Interest Coverage 6.12
Cash Conversion 91.57%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.71
F-Score5
WACC9.51%
ROIC/WACC0.86
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)47.68%
Cap/Sales(5y)38.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-347.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y120.67%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.94%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%12.33%
Revenue Next Year-13.95%
Revenue Next 2Y-3.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.09%
EBIT growth 3Y3.18%
EBIT growth 5YN/A
EBIT Next Year67.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-133.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.24%
OCF growth 3Y22.12%
OCF growth 5Y36.28%